Stock Evaluator: Sartorius Aktiengesellschaft (SOAGY)
Sartorius Aktiengesellschaft SOAGY
$58.48
0.00
0.00%
August 20, 2026 3:58:51 PM
EST
Volume: 1,318
After Hours: $120.37
0.15
|
0.12%
November 10, 2021 7:59 PM
EST
Volume: 72,713
USD
| DELAYED PRICE
| SECTOR | INDUSTRY |
| Health Care | Life Sciences Tools & Services |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers analytical solutions, such as biolayer interferometry systems, high-throughput screening by cytometry systems, process analytical technology and data analytics, cell selection and retrieval, live-cell imaging and analysis systems, and surface plasmon resonance systems; cell culture solutions, including bioreactors and fermenters, cell culture reagents, supplements and matrices, nucleic acid and delivery solutions, cell culture media, and cell lines and buffers; and fluid management products. It also provides lab filtration and purification solutions, lab water purification systems, microtissue technologies, lab weighing, pipettes, tips and dispensers, microbiological testing solutions, lab data and fleet management software, and OEM solutions; and Process chromatography and filtration solutions. The company serves the life science research, biopharmaceutical manufacturing, cell and gene therapy, and applied industries. The company was founded in 1870 and is headquartered in Göttingen, Germany.
Financial Summary
| Share Statistics | SOAGY | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $18,140.0 | $3,076.5 | 85% |
|
| Shares Out (Mil) | na | 96.5 | na |
|
| Institutional Ownership | 33.3% | 90.0% | 14% |
|
| Float (Mil) | 27.4 | 71.5 | 34% |
|
| Beta | 1.47 | 1.22 | 83% |
|
| Avg Daily Volume (000s) | 4 | 710 | 13% |
|
| Price Change (52-week) |
28.3% | 89.4% | 68% |
|
| Growth | SOAGY | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 7.8% | 7.8% | 49% |
|
| Net Income (5yr) | (6.7%) | (13.7%) | 32% |
|
| EPS (5yr) | (6.9%) | 0.7% | 24 |
|
| Dividends (5yr) | 0.3% | 0.0% | 76% |
|
| Cash Flow (5yr) | (30.7%) | (15.0%) | 18% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | SOAGY | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $4,092 | $800 | 71% |
|
| Net Income (TTM) (Mil) | $224 | ($31) | 69% |
|
| EPS (TTM) | na | ($0.300) | na |
|
| Operating Cash Flow (TTM) (Mil) | $1,042 | $47 | 81% |
|
| Net Cash Flow (TTM) (Mil) | ($611) | $5 | 5% |
|
| Long-Term Debt (Q1) (Mil) | $4,168 | $270 | 83% |
|
| Enterprise Value (Q1) (Mil) | $21,342 | $3,795 | 84% |
|
| Valuation | SOAGY | Industry Median |
Percentile (All Stocks) |
|
| P/B | na | 3.68 | na |
|
| P/E | na | 39.8 | na |
|
| Dividend Yield | na | 0.0% | na |
|
| PEG (5yr hist) | na | 5.5 | na |
|
| Ratios | SOAGY | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 45.7% | 47.7% | 57% |
|
| Net Margin | 5.5% | (3.2%) | 50% |
|
| ROA | 2.0% | (4.3%) | 56% |
|
| ROE | 7.1% | (7.9%) | 49% |
|
| Liabilities to Assets | 58.4% | 42.0% | 52% |
|
| F-Score | na | 5 | na |
|
Sartorius Aktiengesellschaft did not pass any screens on 8/20/2026.
